Orion Biotech Opportunities Corp. financial data

Industry
Blank Checks
Location
One Vanderbilt Avenue, 26 Th Floor, New York, NY
State of incorporation
Cayman Islands
Fiscal year end
December 31
Latest financial report
10-K - Q4 2022 - Mar 29, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.08K %
Debt-to-equity -110 %
Return On Equity -110 % -1691%
Return On Assets 4.34 %

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 195M USD -3.13%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 780K USD +40.8%
Operating Income (Loss) -900K USD -43.2%
Net Income (Loss) Attributable to Parent 8.76M USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 266K USD -62.7%
Assets, Current 439K USD -67.5%
Assets 203M USD +0.98%
Accounts Payable, Current 7.72K USD -33.6%
Accrued Liabilities, Current 59.9K USD -14.5%
Liabilities, Current 67.6K USD -17.2%
Liabilities 8.33M USD -44.9%
Retained Earnings (Accumulated Deficit) -7.79M USD +43.3%
Stockholders' Equity Attributable to Parent -7.79M USD +43.3%
Liabilities and Equity 203M USD +0.98%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -137K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 266K USD -62.7%
Preferred Stock, Shares Authorized 5M shares 0%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%